Related Experiment Video
Updated: May 11, 2026

Fabrication of a Bioactive, PCL-based "Self-fitting" Shape Memory Polymer Scaffold
Published on: October 23, 2015
Formulation and characterization of a sortase a inhibitor-loaded PMMA bone cement
Yin-Yu Qi1,2, Lu-Yang Han1,2, Long-Xu Han1
1Bengbu Medical University, The Second People's Hospital of Hefei (Affiliated Hospital) Anhui 230011 China chujianj@mail.ustc.edu.cn xuyang@hfut.edu.cn.
A novel sortase A inhibitor (SrtA I)-loaded bone cement (SLBC) offers prolonged antibacterial activity against Staphylococcus aureus and MRSA. This biocompatible cement shows potential for managing prosthetic joint infections in total joint replacement.
Area of Science:
- Biomaterials Science
- Infectious Diseases
- Orthopedic Surgery
Background:
- Prosthetic joint infections are a significant complication of cemented total joint replacement (TJR).
- Current antibiotic-loaded bone cements have limitations in sustained antibacterial efficacy.
- Sortase A inhibitors offer a novel approach to combat bacterial infections.
Purpose of the Study:
- To develop and evaluate a novel sortase A inhibitor (SrtA I)-loaded bone cement (SLBC) for managing prosthetic joint infections.
- To compare the antibacterial efficacy and material properties of SLBC with conventional gentamicin-loaded bone cement (GS cement).
Main Methods:
- SLBC was formulated with 1-(3,4-dichlorophenyl)-3-(dimethylamino)propyl-1-one hydrochloride (AEEK1) as the SrtA I.
- Antibacterial duration against Staphylococcus aureus (S. aureus) and methicillin-resistant S. aureus (MRSA) was assessed.
- Quasi-static compressive strength, maximum polymerization temperature, and setting time were evaluated according to ISO 5833 standards.
- Biocompatibility and injectability were confirmed through in vitro and in vivo studies using porcine vertebrae.
Main Results:
- SLBC demonstrated a significantly prolonged effective antibacterial duration against both S. aureus and MRSA compared to GS cement.
- The mechanical properties (compressive strength, polymerization temperature, setting time) of SLBC met ISO 5833 standards and were comparable to GS cement.
- In vitro and in vivo studies confirmed the biocompatibility and easy injectability of SLBC into porcine vertebrae.
Conclusions:
- SLBC exhibits superior and prolonged antibacterial activity against key pathogens relevant to prosthetic joint infections.
- SLBC possesses favorable mechanical properties and biocompatibility, comparable to existing bone cements.
- SLBC shows significant potential as an effective therapeutic option for the management of prosthetic joint infections in cemented TJR.
More Related Videos
12:22Synthesis of Thermogelling PolyN-isopropylacrylamide-graft-chondroitin Sulfate Composites with Alginate Microparticles for Tissue Engineering
Published on: October 26, 2016
11:20Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
Published on: March 29, 2018
Related Concept Videos
The Bone Matrix
Mortar Properties
Porosity in Cement Paste
The balance of water to cement in the mix is critical—it...
Plasticizers
Plasticizers function by using surface-active agents to create repulsive electrostatic forces between cement particles. This dispersion enhances the concrete's...
Superplasticizers
Waterproofing and Anti-Bacterial Admixtures in Concrete
Waterproofing admixtures render concrete hydrophobic,...